441 | GOLCADOMIDE, A CEREBLON E3 LIGASE MODULATOR (CELMoD) AGENT ± RITUXIMAB, IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED PHASE 1/2 RESULTS
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
10.1002/hon.70094_441